Sage Therapeutics and Biogen Announce New Analyses from the LANDSCAPE Clinical Development Program of Zuranolone in MDD Presented at the American College of Neuropsychopharmacology (ACNP) Congress - Business Wire
Submitted by Anonymous (not verified) on Wed, 12/08/2021 - 11:30
